Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

United Health Products (UEEC) Shares Outstanding (2016 - 2025)

United Health Products (UEEC) has disclosed Shares Outstanding for 15 consecutive years, with $40.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding fell 83.85% to $40.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $40.3 million, a 83.85% decrease, with the full-year FY2024 number at $46.2 million, down 81.14% from a year prior.
  • Shares Outstanding was $2.8 million for Q3 2025 at United Health Products, down from $257.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $257.3 million in Q2 2025 to a low of $2.8 million in Q1 2025.
  • A 5-year average of $202.4 million and a median of $229.9 million in 2022 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: rose 25.72% in 2021, then crashed 83.85% in 2025.
  • United Health Products' Shares Outstanding stood at $228.7 million in 2021, then grew by 0.96% to $230.9 million in 2022, then grew by 6.03% to $244.8 million in 2023, then plummeted by 81.14% to $46.2 million in 2024, then decreased by 12.67% to $40.3 million in 2025.
  • Per Business Quant, the three most recent readings for UEEC's Shares Outstanding are $40.3 million (Q3 2025), $257.3 million (Q2 2025), and $257.1 million (Q1 2025).